Comment on

• Primary cisplatin, methotrexate and vinblastine aiming at bladder preservation in invasive bladder cancer: multivariate analysis on prognostic factors.

  Angulo JC, Sanchez-Chapado M, Lopez JI, Flores N. Angulo JC, et al. J Urol. 1996 Jun;155(6):1897-902. J Urol. 1996. PMID: 8618282 Clinical Trial.
• Five-year followup of a prospective trial of radical cystectomy and neoadjuvant chemotherapy: Nordic Cystectomy Trial I. The Nordic Cooperative Bladder Cancer Study Group.

  Malmström PU, Rintala E, Wahlqvist R, Hellström P, Hellsten S, Hannisdal E. Malmström PU, et al. J Urol. 1996 Jun;155(6):1903-6. J Urol. 1996. PMID: 8618283 Clinical Trial.
• Reassessment of conservative management for stage T1N0M0 transitional cell carcinoma of the bladder.

  Zhang GK, Uke ET, Sharer WC, Borkon WD, Bernstein SM. Zhang GK, et al. J Urol. 1996 Jun;155(6):1907-9. J Urol. 1996. PMID: 8618284